These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 497571)

  • 1. Effects of monoamine oxidase inhibitor (MAOI) pretreatment on the fate of intraduodenally instilled [14C]-tyramine [proceedings].
    Garcha G; Imrie PR; Marley E; Thomas DV
    Br J Pharmacol; 1979 Nov; 67(3):454P-455P. PubMed ID: 497571
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolites of intraduodenally instilled histamine after pretreatment with monoamine oxidase inhibitors (MAOI) [proceedings].
    Imrie PR; Marley E; Thomas DV
    Br J Pharmacol; 1979 May; 66(1):73P-74P. PubMed ID: 454959
    [No Abstract]   [Full Text] [Related]  

  • 3. [14C]-beta-phenethylamine, its distribution after administration by various routes to cats, and the effects of monoamine oxidase inhibitors.
    Garcha G; Imrie PR; Marley E; Thomas DV
    Br J Pharmacol; 1985 Dec; 86(4):877-88. PubMed ID: 4075021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF
    Vopr Med Khim; 1997; 43(6):494-503. PubMed ID: 9503566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A
    Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamining the dietary restrictions with procarbazine (an MAOI).
    Maxwell MB
    Cancer Nurs; 1980 Dec; 3(6):451-7. PubMed ID: 6903477
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase B inhibition and the "cheese effect".
    Youdim MB; Finberg JP
    J Neural Transm Suppl; 1987; 25():27-33. PubMed ID: 3480939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary tyramine and other pressor amines in MAOI regimens: a review.
    McCabe BJ
    J Am Diet Assoc; 1986 Aug; 86(8):1059-64. PubMed ID: 3525654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAOI and monosodium glutamate interaction.
    Lee S; Wing YK
    J Clin Psychiatry; 1991 Jan; 52(1):43. PubMed ID: 1988422
    [No Abstract]   [Full Text] [Related]  

  • 13. "Much ado about nothing": monoamine oxidase inhibitors, drug interactions, and dietary tyramine.
    Gillman K
    CNS Spectr; 2017 Oct; 22(5):385-387. PubMed ID: 28148312
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of inhibition of monoamine oxidase on the actions and interactions of norepinephrine, tyramine and other drugs on guinea-pig left atrium.
    Furchgott RF; Sanchez Garcia P
    J Pharmacol Exp Ther; 1968 Sep; 163(1):98-122. PubMed ID: 5673720
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation.
    Christmas AJ; Hall DW; Hayward A; Maxwell DR
    Br J Pharmacol; 1970 May; 39(1):207P-208P. PubMed ID: 5420104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroglycerin (glyceryl trinitrate) as a monoamine oxidase inhibitor.
    Ogawa K; Gudbjarnason S; Bing RJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):449-55. PubMed ID: 4960617
    [No Abstract]   [Full Text] [Related]  

  • 18. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.